Our previous studies in hypercholesterolemic apoE knockout mice showed that SGC707 treatment was not only associated with a reduction in the hepatic steatosis extent but also with a decrease in gonadal white adipose tissue adipocyte size6. The gene discussed is APOE; the disease is fatty liver disease.